Kyle Rose
Stock Analyst at Canaccord Genuity
(3.22)
# 1,074
Out of 4,761 analysts
120
Total ratings
51.02%
Success rate
12.2%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FNA Paragon 28 | Downgrades: Hold | n/a | $13.05 | - | 8 | Jan 29, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $386.41 | +12.57% | 20 | Jan 29, 2025 | |
| PODD Insulet | Maintains: Buy | $226 → $234 | $288.29 | -18.83% | 15 | May 10, 2024 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $84.12 | -15.60% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $43.90 | +61.73% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $18.97 | +15.97% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.60 | +525.00% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $10.66 | +106.38% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $89.34 | +67.90% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $14.62 | +1,746.79% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $18.00 | +50.00% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.84 | +428.17% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $18.50 | -18.92% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $166.79 | -26.85% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $3.88 | +3.09% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $9.95 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $103.63 | +20.62% | 7 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $55 | $25.72 | +113.84% | 5 | Apr 30, 2021 |
Paragon 28
Jan 29, 2025
Downgrades: Hold
Price Target: n/a
Current: $13.05
Upside: -
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $386.41
Upside: +12.57%
Insulet
May 10, 2024
Maintains: Buy
Price Target: $226 → $234
Current: $288.29
Upside: -18.83%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $84.12
Upside: -15.60%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $43.90
Upside: +61.73%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $18.97
Upside: +15.97%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.60
Upside: +525.00%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $10.66
Upside: +106.38%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $89.34
Upside: +67.90%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $14.62
Upside: +1,746.79%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $18.00
Upside: +50.00%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $2.84
Upside: +428.17%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $18.50
Upside: -18.92%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $166.79
Upside: -26.85%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $3.88
Upside: +3.09%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $9.95
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $103.63
Upside: +20.62%
Apr 30, 2021
Maintains: Buy
Price Target: $53 → $55
Current: $25.72
Upside: +113.84%